Regulation of complement activity by vaccinia virus complement-control protein

Journal of Infectious Diseases

Volumn 166, Issue 6, 1992, Pages 1245-1250

  McKenzie, Robin ^a   Kotwal, Girish J ^a,b   Moss, Bernard ^a   Hammer, C H ^a   Frank, M M ^a,c  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b James N Gamble Inst of Med Res   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIOLYSIS; BINDING AFFINITY; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; ENZYME ACTIVITY; GENETIC REGULATION; HOST RESISTANCE; HUMAN; HUMAN CELL; ISOTOPE LABELING; OPSONIZATION; PRIORITY JOURNAL; PROTEIN SECRETION; REGULATORY MECHANISM; VACCINIA VIRUS; VIRULENCE;

COMPLEMENT 3; COMPLEMENT 3 CONVERTASE; COMPLEMENT 3B; COMPLEMENT 4; COMPLEMENT 4B; COMPLEMENT ACTIVATION; COMPLEMENT INACTIVATORS; COMPLEMENT PATHWAY, ALTERNATIVE; COMPLEMENT PATHWAY, CLASSICAL; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; HUMAN; VACCINIA VIRUS; VIRAL PROTEINS; VIRULENCE;

EID: 0026478547     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/166.6.1245     Document Type: Article

References (20)

1. Friedman HM, Cohen GH, Eisenberg RJ, Seidel CA, Cines DB. Glycoprotein C of herpes simplex virus 1 acts as a receptor for the C3b complement component on infected cells. Nature 1984;309:633-5.
2. Fries LF, Friedman HM, Cohen GH, Eisenberg RJ, Hammer CH, Frank MM. Glycoprotein C of herpes simplex virus 1 is an inhibitor of the complement cascade. J Immunol 1986; 137:1636-41.
3. Kubota Y, Gaither TA, Cason J, O’Shea JJ, Lawley TJ. Characterization of the C3 receptor induced by herpes simplex type 1 infection of human epidermal, endothelial, and A431 cells. J Immunol 1987;138:1137-42.
4. McNearney TA, Odell C, Holers VM, Spear PG, Atkinson JP. Herpes simplex virus glycoproteins gC-1 and gC-2 bind to the third component of complement and provide protection against complement- mediated neutralization of viral infectivity. J Exp Med 1987; 166:1525-35.
5. Harris SL, Frank I, Yee A, Cohen GH, Eisenberg RJ, Friedman HM. Glycoprotein C of herpes simplex virus type 1 prevents complement- mediated cell lysis and virus neutralization. J Infect Dis 1990;162:331-7.
6. Tal-Singer R, Seidel-Dugan C, Fries L, et al. Herpes simplex virus glycoprotein C is a receptor for complement component iC3b. J Infect Dis 1991;164:750-3.
7. Mold C, Bradt BM, Nemerow GR, Cooper NR. Epstein-Barr virus regulates activation and processing of the third component of complement. J Exp Med 1988;168:949-69.
8. Dahlback B, Smith CA, Mtiller-Eberhard HJ. Visualization of human C4b-binding protein and its complexes with vitamin K-dependent protein S and complement protein C4b. Proc Natl Acad Sci USA 1983;80:3461-5.
9. Kotwal GJ, Moss B. Vaccinia virus encodes a secretory polypeptide structurally related to complement control proteins. Nature 1988;335:176-8.
10. Kotwal GJ, Isaacs SN, McKenzie R, Frank MM, Moss B. Inhibition of the complement cascade by the major secretory protein of vaccinia virus. Science 1990;250:827-30.
11. Isaacs SN, Kotwal GJ, Moss B. Vaccinia virus complement-control protein prevents antibody dependent complement-enhanced neutralization of infectivity and contributes to virulence. Proc Natl Acad Sci USA 1992;89:628-32.
12. Hammer CH, Wirtz GH, Renfer L, Gresham HD, Tack BF. Large scale isolation of functionally active components of the human complement system. J Biol Chem 1981;256:3995-4006.
13. Basta M, Hammer CH. A rapid FPLC method for purification of the third component of human and guinea pig complement. J Immunol Methods 1991;142:39-44.
14. Rapp HJ, Borsos T, eds. Molecular basis of complement action. New York: Meredith, 1970:9-21.
15. Newman SL, Johnston RB Jr. Role of binding through C3b and IgG in polymorphonuclear neutrophil function: studies with trypsin-generated C3b. J Immunol 1979;123:1839-46.
16. Ellman L, Green I, Frank MM. Genetically controlled total deficiency of the fourth component of complement in the guinea pig. Science 1970;170:74-5.
17. Gaither TA, Hammer CH, Frank MM. Studies of the molecular mechanisms of C3b inactivation and a simplified assay of/S1H and the C3b inactivator. J Immunol 1979; 123:1195-204.
18. Gaither TA, Frank MM. Complement. In: Henry JB, ed. Clinical diagnosis and management by laboratory methods. Philadelphia: WB Saunders, 1984:1245-61.
19. Kotwal GJ, Moss B. Analysis of a large cluster of nonessential genes deleted from a vaccinia virus terminal transposition mutant. Virology 1988;167:524-37.
20. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5.